EUVIMEDEUVIMED entdecken
Crossref

Atorvastatin-induced neuroprotection against NMDA-induced retinal excitotoxicity: association with altered retinal PPARα and PPARγ expression

Jing Yi Wong, Heethal Jaiprakash, Renu Agarwal, Igor Iezhitsa, Purushotham Krishnappa, Siew Tung Wong, Maxim A. Perfilev, Pavel M. Vassiliev

International Journal of Ophthalmology · 18.12.2026 · 19 (12) · 2360-2372

DOI: 10.18240/ijo.2026.12.06 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Ophthalmology, erschienen am 18.12.2026. Verfasst von Jing Yi Wong und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: To explore the effect of atorvastatin on the retinal expression of peroxisome proliferator-activated receptors (PPARs) and its anti-apoptotic and pro-survival effects against excitotoxic retinal injury. METHODS: An in-silico study was conducted to determine the affinity of statins towards PPARs and the one with maximum affinity was chosen for further studies. Rats were intravitreally administered with N-methyl-D-aspartate (NMDA), with or without statin pre-treatment, at doses ranging from 0.1 to 100 µmol/L. Retinal Bcl-2-associated X protein (BAX), Bcl2, caspase-3, RNA-binding protein with multiple splicing (RBPMS) expressions were determined to assess pro-apoptotic and pro-survival effects. To further corroborate the findings, haematoxylin & eosin (H&E)-stained retinal sections were examined to evaluate retinal morphology. Furthermore, the effect of atorvastatin on retinal expression of PPARs in the presence and absence of excitotoxic injury was determined. RESULTS: Among the six statins, atorvastatin demonstrated the highest affinity towards PPARα and PPARγ receptors. Among five doses, atorvastatin at a dose of 20 µmol/L dose showed the most significant reduction in BAX/Bcl-2 and cleaved/procaspase-3 ratios (P

Zitieren

APA

Wong, J. Y., Jaiprakash, H., Agarwal, R., Iezhitsa, I., Krishnappa, P., Wong, S. T., Perfilev, M. A., & Vassiliev, P. M. (2026). Atorvastatin-induced neuroprotection against NMDA-induced retinal excitotoxicity: association with altered retinal PPARα and PPARγ expression. International Journal of Ophthalmology, 19(12), 2360-2372. https://doi.org/10.18240/ijo.2026.12.06

Vancouver

Wong JY, Jaiprakash H, Agarwal R, Iezhitsa I, Krishnappa P, Wong ST, et al. Atorvastatin-induced neuroprotection against NMDA-induced retinal excitotoxicity: association with altered retinal PPARα and PPARγ expression. International Journal of Ophthalmology. 2026;19(12):2360-2372. doi:10.18240/ijo.2026.12.06

BibTeX
@article{Wong2026,
  author = {Wong, Jing Yi and Jaiprakash, Heethal and Agarwal, Renu and Iezhitsa, Igor and Krishnappa, Purushotham and Wong, Siew Tung and Perfilev, Maxim A. and Vassiliev, Pavel M.},
  title = {Atorvastatin-induced neuroprotection against NMDA-induced retinal excitotoxicity: association with altered retinal PPARα and PPARγ expression},
  journal = {International Journal of Ophthalmology},
  year = {2026},
  volume = {19},
  number = {12},
  pages = {2360--2372},
  doi = {10.18240/ijo.2026.12.06}
}
Kostenlos starten →